Equasens Société anonyme

Informe acción ENXTPA:EQS

Capitalización de mercado: €665.1m

Equasens Société anonyme Dirección

Dirección controles de criterios 2/4

El CEO de Equasens Société anonyme es Denis Supplisson, nombrado en Apr 2022, tiene una permanencia de 2.67 años. posee directamente un 0% de las acciones de la empresa, con un valor de €465.59. La antigüedad media del equipo directivo y de la junta directiva es de 1.9 años y 13 años, respectivamente.

Información clave

Denis Supplisson

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO2.7yrs
Participación del CEO0.00007%
Permanencia media de la dirección1.9yrs
Promedio de permanencia en la Junta Directiva13yrs

Actualizaciones recientes de la dirección

Recent updates

The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 03
The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Sep 28
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price

Jul 15
Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price

Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Jun 22
Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Jun 07
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

Apr 03
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Mar 08
At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Feb 14
Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 27
Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

Nov 29
Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

Oct 28
These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Sep 27
A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Aug 05
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Jun 11
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 08
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Apr 04
What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Feb 13
Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 26
Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Dec 21
At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Dec 07
Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Nov 12
Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Oct 27
Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Oct 12
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

When Should You Buy Equasens Société anonyme (EPA:EQS)?

Sep 09
When Should You Buy Equasens Société anonyme (EPA:EQS)?

With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Aug 24
With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Jul 28
Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Jun 10
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

May 27
Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

May 22
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Apr 25
Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Feb 23
Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Feb 09
Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Jan 25
Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Jan 06
Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Nov 14
Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Oct 30
Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Sep 28
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Jul 18
Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Jun 24
Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Apr 08
Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Mar 24
Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 03
Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Feb 09
Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

Jan 12
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Dec 15
What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Denis Supplisson en comparación con los beneficios de Equasens Société anonyme?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

€42m

Mar 31 2024n/an/a

€45m

Dec 31 2023n/an/a

€47m

Jun 30 2023n/an/a

€48m

Mar 31 2023n/an/a

€47m

Dec 31 2022€400k€176k

€46m

Jun 30 2022n/an/a

€42m

Mar 31 2022n/an/a

€41m

Dec 31 2021€353k€133k

€39m

Sep 30 2021n/an/a

€37m

Jun 30 2021n/an/a

€35m

Mar 31 2021n/an/a

€33m

Dec 31 2020€371k€133k

€31m

Sep 30 2020n/an/a

€29m

Jun 30 2020n/an/a

€27m

Mar 31 2020n/an/a

€27m

Dec 31 2019€225k€133k

€27m

Sep 30 2019n/an/a

€27m

Jun 30 2019n/an/a

€26m

Mar 31 2019n/an/a

€26m

Dec 31 2018€208k€128k

€25m

Compensación vs. Mercado: Datos insuficientes para determinar si la compensación total de Denis es razonable en comparación con empresas de tamaño similar en el mercado French.

Compensación vs. Ingresos: La compensación de Denis ha sido consistente con los resultados de la empresa en el último año.

CEO

Denis Supplisson (55 yo)

2.7yrs

Permanencia

€400,201

Compensación

Mr. Denis Supplisson serves as Chief Executive Officer at Pharmagest Interactive SA since April 22, 2022. He served as Deputy Managing Director/Deputy Chief Executive Officer & Manager of the Europe Pharma...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Thierry Chapusot
Founder & Chairman of the Board14.9yrssin datos0.036%
€ 237.2k
Grégoire De Rotalier
Deputy CEO4.4yrs€428.66k0.000070%
€ 465.6
Denis Supplisson
Chief Executive Officer & Director2.7yrs€400.20k0.000070%
€ 465.6
Dominique Pautrat
Directorno data€330.17k0.16%
€ 1.1m
Frederique Schmidt
Group Chief Administrative & Financial Officer1.9yrssin datossin datos
Noelle Stoulig
Head of Communicationsless than a yearsin datossin datos
Sabrina Gharbi
Chief Human Resources Officer5.2yrssin datossin datos
Dominique Goursaud
Head of the Medical Solutions Divisionless than a yearsin datossin datos
Damien Valicon
Deputy MD & Head of the Pharmagest Divisionless than a yearsin datossin datos

1.9yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de EQS no se considera experimentado ( 1.9 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Thierry Chapusot
Founder & Chairman of the Board14.9yrssin datos0.036%
€ 237.2k
Grégoire De Rotalier
Deputy CEO4.4yrs€428.66k0.000070%
€ 465.6
Denis Supplisson
Chief Executive Officer & Director11.9yrs€400.20k0.000070%
€ 465.6
Dominique Pautrat
Director15.5yrs€330.17k0.16%
€ 1.1m
Daniel Antoine
Director22.6yrs€6.91k0.0033%
€ 22.1k
Hugues Moreaux
Director13.9yrssin datossin datos
François Jacquel
Director13.9yrs€7.07k0.0027%
€ 18.3k
Anne Lhote
Director13.5yrssin datos0.0046%
€ 30.5k
Sophie Mayeux
Independent Director12.5yrs€6.76k0.00017%
€ 1.1k
Celine Gris
Independent Director7.5yrs€6.91k0.00013%
€ 864.7
Emilie Lecomte
Director7.5yrs€604.000.00011%
€ 731.6
Anne Philipona-Hintzy
Independent Director1.5yrssin datos0.000010%
€ 66.5

13.0yrs

Permanencia media

57.5yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de EQS son experimentados ( 13 años antigüedad media).

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2024/12/31 18:44
Precio de las acciones al final del día2024/12/31 00:00
Beneficios2024/06/30
Ingresos anuales2023/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* ejemplo para los valores estadounidenses, para los no estadounidenses se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Obtenga más información aquí.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en .

Fuentes analistas

Equasens Société anonyme está cubierta por 7 analistas. 6 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Jean-Baptiste BouchetCIC Market Solutions (ESN)
Robin LeclercDegroof Petercam
Yann de PeyrelongueGilbert Dupont